Topics

Lucid secures FDA breakthrough device designation for EsoGuard Esophageal DNA Test

10:11 EST 12 Feb 2020 | Compelo Medical Devices

Lucid Diagnostics, a subsidiary of medical device company PAVmed, has obtained the US Food and Drug Administration (FDA) breakthrough device designation for its EsoGuard Esophageal DNA Test. FDA

The post Lucid secures FDA breakthrough device designation for EsoGuard Esophageal DNA Test appeared first on NS Medical Devices.

Original Article: Lucid secures FDA breakthrough device designation for EsoGuard Esophageal DNA Test

NEXT ARTICLE

More From BioPortfolio on "Lucid secures FDA breakthrough device designation for EsoGuard Esophageal DNA Test"

Quick Search

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...